NCT01139645View on ClinicalTrials.gov

The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Calcium Metabolism Disorders
Interventions
DRUG

Rabeprazole or Esomeprazole or Lanzoprazole

1/3 of the patients are taking Pariet (Rabeprazole) 20 mg once daily 1/3 of the patients are taking Nexium (Esomeprazole) 40 mg once daily 1/3 of the patients are taking Lanzor (Lanzoprazole) 30 mg once daily

Trial Locations (1)

Unknown

American University of Beirut - Medical Center, Beirut

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

American University of Beirut Medical Center

OTHER